Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer

Go back to Sarepta (SRPT) Wins Key PTO Decision on Composition of Matter Patents - Oppenheimer

Form 8-K Sarepta Therapeutics, For: Sep 19

September 19, 2016 1:43 PM EDT

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K

... More